| 000 | 01278 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517085933.0 | ||
| 264 | 0 | _c20170106 | |
| 008 | 201701s 0 0 ger d | ||
| 022 | _a1433-0407 | ||
| 024 | 7 |
_a10.1007/s00115-016-0102-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHamer, H | |
| 245 | 0 | 0 |
_a[Effect of the German Act on the reform of the market for medicinal products (AMNOG) on the quality of neurological and psychiatric treatment]. _h[electronic resource] |
| 260 |
_bDer Nervenarzt _cApr 2016 |
||
| 300 |
_a351-2 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aDrug Approval _xeconomics |
| 650 | 0 | 4 |
_aDrug Industry _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aGovernment Regulation |
| 650 | 0 | 4 |
_aHealth Care Reform _xeconomics |
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 |
_aMarketing of Health Services _xeconomics |
| 650 | 0 | 4 |
_aNeurology _xeconomics |
| 650 | 0 | 4 |
_aOutcome Assessment, Health Care _xeconomics |
| 650 | 0 | 4 |
_aPsychotherapy _xeconomics |
| 650 | 0 | 4 |
_aQuality Assurance, Health Care _xeconomics |
| 700 | 1 | _aMeyer-Lindenberg, A | |
| 773 | 0 |
_tDer Nervenarzt _gvol. 87 _gno. 4 _gp. 351-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00115-016-0102-4 _zAvailable from publisher's website |
| 999 |
_c25874142 _d25874142 |
||